The total artificial heart (TAH) is a form of mechanical circulatory support in which the
patient's native ventricles and valves are explanted and replaced by a pneumatically …

Cardiac arrest in patients on mechanical support is a new phenomenon brought about by
the increased use of this therapy in patients with end-stage heart failure. This American …

Several groups have reported extended survival of genetically engineered pig organs in
nonhuman primates, varying from almost 10 months for life-supporting kidney grafts and …

Mechanical circulatory support devices have been increasingly used for long-term support.
We reviewed outcomes in all patients supported with a SynCardia total artificial heart (TAH) …

According to the Centers for Disease Control, heart failure (HF) remains a pervasive
condition with high morbidity and mortality, affecting 5.8 million people in the United States …

Abstract The CARMAT-Total Artificial Heart (C-TAH) is designed to provide heart
replacement therapy for patients with end-stage biventricular failure. This report details the …

Introducción La insuficiencia cardiaca (IC) terminal es una afección cuyo único tratamiento
exitoso a largo plazo, con una supervivencia de más de 10 años, es el trasplante cardíaco …

Heart failure (HF) is a concerning health care problem associated with significant morbidity,
mortality, and costs. There are approximately 825,000 new HF cases annually. An estimated …

Introduction End-stage heart failure (HF) is a condition whose only successful long-term
treatment, with a survival of more than 10 years, is heart transplantation. However, limited …

The aim of this review is to describe the current use, indications, and outcomes of the
Syncardia temporary total artificial heart (TAH)(Syncardia Systems, Tucson, AZ, USA), the …